Zimmer Biomet Holdings (ZBH) Revenue (2009 - 2026)

Zimmer Biomet Holdings' Revenue history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• On a quarterly basis, Revenue rose 9.3% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $8.4 billion, a 9.23% increase from a year earlier, with the FY2025 full-year figure at $8.2 billion, up 7.2% from the prior year.
• Revenue declined to $2.1 billion in Q1 2026 per ZBH's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Revenue topped out at $2.2 billion in Q4 2025 and bottomed at $1.7 billion in Q1 2022.
• The 5-year median for Revenue is $1.9 billion (2024), against an average of $1.9 billion.
• Across the five-year window, Revenue fell 0.93% in 2022 and rose 10.9% in 2025, its largest moves.
• Year by year, Revenue stood at $1.8 billion in 2022, then climbed by 6.3% to $1.9 billion in 2023, then rose by 4.28% to $2.0 billion in 2024, then rose by 10.9% to $2.2 billion in 2025, then dropped by 7.0% to $2.1 billion in 2026.
• Per Business Quant, the three latest ZBH Revenue figures stand at $2.1 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.0 billion (Q3 2025).